Haruka Miki1, Hong Pei1, Donald Tom Gracias1, Joel Linden1, Michael Croft2. 1. Center of Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, Calif. 2. Center of Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, Calif; Department of Medicine, University of California San Diego, La Jolla, Calif. Electronic address: mick@lji.org.
Abstract
BACKGROUND: Poor clearance of apoptotic cells has been suggested to contribute to severe asthma, but whether uptake of apoptotic cells by lung phagocytes might dampen house dust mite (HDM)-induced lung inflammation has not been shown. OBJECTIVES: This study investigated whether apoptotic cell engulfment in the murine lung impacts the development of allergen-induced asthmatic airway inflammation and which immune modulating mechanisms were activated. METHODS: Apoptotic cells were infused into the lungs of mice challenged with HDM allergen and lung inflammation, expression of suppressive molecules, and induction of regulatory T cells were monitored. Additionally, an adenosine receptor agonist was tested to study the mechanism of suppression elicited by apoptotic cells. RESULTS: Apoptotic cell uptake by lung alveolar macrophages suppressed HDM-driven allergic asthma. This was associated with promoting the regulatory T cell-inducing molecule retinoic acid, inhibiting inflammatory cytokine production, and making macrophages more susceptible to receiving suppressive signals from adenosine. Correspondingly, adenosine receptor agonist treatment also limited HDM-driven allergic airway inflammation through an action on alveolar macrophages. CONCLUSIONS: These data provide insight into the mechanisms by which lung macrophages dampen allergen-induced airway inflammation. They suggest that targeting lung macrophages to increase their phagocytic capacity, enhance their ability to make retinoic acid, dampen their capacity to make inflammatory cytokines, and increase their responsiveness to adenosine, could be useful to suppress allergic responses.
BACKGROUND: Poor clearance of apoptotic cells has been suggested to contribute to severe asthma, but whether uptake of apoptotic cells by lung phagocytes might dampen house dust mite (HDM)-induced lung inflammation has not been shown. OBJECTIVES: This study investigated whether apoptotic cell engulfment in the murine lung impacts the development of allergen-induced asthmatic airway inflammation and which immune modulating mechanisms were activated. METHODS: Apoptotic cells were infused into the lungs of mice challenged with HDM allergen and lung inflammation, expression of suppressive molecules, and induction of regulatory T cells were monitored. Additionally, an adenosine receptor agonist was tested to study the mechanism of suppression elicited by apoptotic cells. RESULTS: Apoptotic cell uptake by lung alveolar macrophages suppressed HDM-driven allergic asthma. This was associated with promoting the regulatory T cell-inducing molecule retinoic acid, inhibiting inflammatory cytokine production, and making macrophages more susceptible to receiving suppressive signals from adenosine. Correspondingly, adenosine receptor agonist treatment also limited HDM-driven allergic airway inflammation through an action on alveolar macrophages. CONCLUSIONS: These data provide insight into the mechanisms by which lung macrophages dampen allergen-induced airway inflammation. They suggest that targeting lung macrophages to increase their phagocytic capacity, enhance their ability to make retinoic acid, dampen their capacity to make inflammatory cytokines, and increase their responsiveness to adenosine, could be useful to suppress allergic responses.
Authors: Sayuri Yamazaki; Diana Dudziak; Gordon F Heidkamp; Christopher Fiorese; Anthony J Bonito; Kayo Inaba; Michel C Nussenzweig; Ralph M Steinman Journal: J Immunol Date: 2008-11-15 Impact factor: 5.422
Authors: Ruby Fernandez-Boyanapalli; Elena Goleva; Christena Kolakowski; Elysia Min; Brian Day; Donald Y M Leung; David W H Riches; Donna L Bratton; E Rand Sutherland Journal: J Allergy Clin Immunol Date: 2012-11-13 Impact factor: 10.793
Authors: Jennifer M Felton; Christopher D Lucas; David A Dorward; Rodger Duffin; Tiina Kipari; Sonja Vermeren; Calum T Robb; Kenneth G MacLeod; Bryan Serrels; Jürgen Schwarze; Christopher Haslett; Ian Dransfield; Adriano G Rossi Journal: J Allergy Clin Immunol Date: 2018-02-08 Impact factor: 10.793
Authors: Melanie Erriah; Kavita Pabreja; Michael Fricker; Katherine J Baines; Louise E Donnelly; Johan Bylund; Anna Karlsson; Jodie L Simpson Journal: Respir Res Date: 2019-01-03
Authors: Mara Gilardi; Robert Saddawi-Konefka; Victoria H Wu; Miguel Angel Lopez-Ramirez; Zhiyong Wang; Fernando Soto; Dana J Ramms; Marco Proietto; Zbigniew Mikulski; Haruka Miki; Andrew Sharabi; Daniel Kupor; Ricardo Rueda; Daniel P Hollern; Joseph Wang; J Silvio Gutkind Journal: Mol Cancer Ther Date: 2022-04-01 Impact factor: 6.009